A new report has revealed favourable insights into clinical trials in Australia, where more than $1 billion is invested each year by both government and industry. [ + ]

The Australian Government has announced that it will permit the export of medicinal cannabis products. [ + ]

Exopharm has finalised testing for its disruptive LEAP technology, taking a further step in bringing extracellular vesicles as an acellular therapy to treat patients with degenerative conditions. [ + ]

An international collaboration, led by Melbourne researchers, has solved a longstanding malaria mystery. [ + ]

Melbourne researchers have developed an ingestible capsule that detects and measures gut gases — hydrogen, carbon dioxides and oxygen — in real time. [ + ]

US scientists have revealed for the first time the atomic-level structure of a promising drug target for conditions such as stroke and traumatic brain injury, with the results published in the journal Nature. [ + ]

Virtual reality technology is allowing multiple scientists to see inside a human cell at the same time, giving researchers a 3D tool to improve doctor interaction and help analyse how cancer drugs work. [ + ]

Scientists have 'mined' the information stored in bacteria genomes, which they suggest hold the blueprints for new, effective cancer-targeting compounds. [ + ]

Scientists have developed a new approach to identify important undiscovered functions of proteins. [ + ]

Artificially intelligent computer algorithms have been found to equal human pathologists in detecting metastases of breast cancer in lymph nodes. [ + ]

Nutraceuticals are expanding into new territories as the need for new therapies increases, according to GBI Research. [ + ]

Researchers have discovered that a protein called Runx3 programs killer T cells to establish residence in tumours and infection sites. [ + ]

Australian epilepsy researchers have used a mobile, brain-inspired processor to bring personalised seizure prediction a step closer to a reality. [ + ]

Merck has entered into an agreement with Avanti Polar Lipids to be the exclusive multinational distributor of the latter's research lipids portfolio outside of the United States. [ + ]

Queensland researchers have found that 38% of cancer deaths in Australia, or 16,700 each year, could potentially be avoided — mostly through lifestyle changes. [ + ]